-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: vTv Therapeutics Appoints Michael Tung, M.D., MBA, to Chief Financial Officer as Company Reinitiates Phase 3 Trial of Oral T1D Adjunctive Therapy to Insulin

Dow Jones·05/19/2025 13:00:00

Please log in to view news